BAUSCH HEALTH COMPANIES INCBAUSCH HEALTH COMPANIES INCBAUSCH HEALTH COMPANIES INC

BAUSCH HEALTH COMPANIES INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.79 B‬CAD
−0.66CAD
‪−799.01 M‬CAD
‪11.82 B‬CAD
‪324.45 M‬
Beta (1Y)
0.92
Employees (FY)
‪20.27 K‬
Change (1Y)
+370 +1.86%
Revenue / Employee (1Y)
‪439.94 K‬CAD
Net income / Employee (1Y)
‪−29.74 K‬CAD

About BAUSCH HEALTH COMPANIES INC


CEO
Thomas J. Appio
Headquarters
Laval
Founded
1994
FIGI
BBG000DC8S17
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
BHC4634780
Bausch Health Companies Inc. 8.5% 31-JAN-2027
Yield to maturity
20.09%
Maturity date
Jan 31, 2027
BHC4832634
Bausch Health Companies Inc. 7.0% 15-JAN-2028
Yield to maturity
19.31%
Maturity date
Jan 15, 2028
BHC4832637
Bausch Health Companies Inc. 7.25% 30-MAY-2029
Yield to maturity
18.10%
Maturity date
May 30, 2029
BHC4986567
Bausch Health Companies Inc. 6.25% 15-FEB-2029
Yield to maturity
17.54%
Maturity date
Feb 15, 2029
BHC4928364
Bausch Health Companies Inc. 5.25% 30-JAN-2030
Yield to maturity
17.23%
Maturity date
Jan 30, 2030
BHC4927761
Bausch Health Companies Inc. 5.0% 30-JAN-2028
Yield to maturity
16.83%
Maturity date
Jan 30, 2028
BHC5082241
Bausch Health Companies Inc. 5.0% 15-FEB-2029
Yield to maturity
16.70%
Maturity date
Feb 15, 2029
BHC5081958
Bausch Health Companies Inc. 5.25% 15-FEB-2031
Yield to maturity
16.19%
Maturity date
Feb 15, 2031
BHC5524410
Canada Treasury Bonds 14.0% 15-OCT-2030
Yield to maturity
16.09%
Maturity date
Oct 15, 2030
BVFC
BAUSCH HEALTH COS 17/25
Yield to maturity
15.13%
Maturity date
Dec 15, 2025
BVFD
BAUSCH HLTH 20/31 144A
Yield to maturity
14.96%
Maturity date
Feb 15, 2031

Explore more bonds 

Frequently Asked Questions


The current price of BHC is 13.01 CAD — it has decreased by −0.46% in the past 24 hours. Watch BAUSCH HEALTH COMPANIES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange BAUSCH HEALTH COMPANIES INC stocks are traded under the ticker BHC.
BHC stock has risen by 0.54% compared to the previous week, the month change is a 18.27% rise, over the last year BAUSCH HEALTH COMPANIES INC has showed a 30.75% increase.
We've gathered analysts' opinions on BAUSCH HEALTH COMPANIES INC future price: according to them, BHC price has a max estimate of 16.73 CAD and a min estimate of 4.15 CAD. Watch BHC chart and read a more detailed BAUSCH HEALTH COMPANIES INC stock forecast: see what analysts think of BAUSCH HEALTH COMPANIES INC and suggest that you do with its stocks.
BHC reached its all-time high on Aug 6, 2015 with the price of 347.84 CAD, and its all-time low was 5.10 CAD and was reached on Jul 28, 2022. View more price dynamics on BHC chart.
See other stocks reaching their highest and lowest prices.
BHC stock is 1.86% volatile and has beta coefficient of 0.92. Track BAUSCH HEALTH COMPANIES INC stock price on the chart and check out the list of the most volatile stocks — is BAUSCH HEALTH COMPANIES INC there?
Today BAUSCH HEALTH COMPANIES INC has the market capitalization of ‪4.78 B‬, it has increased by 0.98% over the last week.
Yes, you can track BAUSCH HEALTH COMPANIES INC financials in yearly and quarterly reports right on TradingView.
BAUSCH HEALTH COMPANIES INC is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
BHC earnings for the last quarter are 1.59 CAD per share, whereas the estimation was 1.42 CAD resulting in a 12.36% surprise. The estimated earnings for the next quarter are 1.56 CAD per share. See more details about BAUSCH HEALTH COMPANIES INC earnings.
BAUSCH HEALTH COMPANIES INC revenue for the last quarter amounts to ‪3.50 B‬ CAD, despite the estimated figure of ‪3.35 B‬ CAD. In the next quarter, revenue is expected to reach ‪3.51 B‬ CAD.
BHC net income for the last quarter is ‪−115.94 M‬ CAD, while the quarter before that showed ‪13.68 M‬ CAD of net income which accounts for −947.33% change. Track more BAUSCH HEALTH COMPANIES INC financial stats to get the full picture.
No, BHC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has ‪20.27 K‬ employees. See our rating of the largest employees — is BAUSCH HEALTH COMPANIES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAUSCH HEALTH COMPANIES INC EBITDA is ‪4.16 B‬ CAD, and current EBITDA margin is 32.71%. See more stats in BAUSCH HEALTH COMPANIES INC financial statements.
Like other stocks, BHC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAUSCH HEALTH COMPANIES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BAUSCH HEALTH COMPANIES INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BAUSCH HEALTH COMPANIES INC stock shows the neutral signal. See more of BAUSCH HEALTH COMPANIES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.